Abstract:Objective : EID3 (EP300-interacting inhibitor of differentiation) was identified as a novel member of EID family and plays a pivotal role in colorectal cancer development. However, its role in glioma remained elusive. In current study, we identified EID3 as a novel oncogenic molecule in human glioma and is critical for glioma cell survival, proliferation and invasion.Methods : A total of five patients with glioma were recruited in present study and fresh glioma samples were removed from patients. Four weeks old male non-obese diabetic severe combined immune deficiency (NOD/SCID) mice were used as transplant recipient models. The subcutaneous tumor size was calculated and recorded every week with vernier caliper. EID3 and AMP-activated protein kinase α1 (AMPKα1) expression levels were confirmed by real-time polymerase chain reaction and Western blot assays. Colony formation assays were performed to evaluate cell proliferation. Methyl thiazolyl tetrazolium (MTT) assays were performed for cell viability assessment. Trypan blue staining approach was applied for cell death assessment. Cell Apoptosis DNA ELISA Detection Kit was used for apoptosis assessment.Results : EID3 was preferentially expressed in glioma tissues/cells, while undetectable in astrocytes, neuronal cells, or normal brain tissues. EID3 knocking down significantly hindered glioma cell proliferation and invasion, as well as induced reduction of cell viability, apoptosis and cell death. EID3 knocking down also greatly inhibited tumor growth in SCID mice. Knocking down of AMPKα1 could effectively rescue glioma cells from apoptosis and cell death caused by EID3 absence, indicating that AMPKα1 acted as a key downstream regulator of EID3 and mediated suppression effects caused by EID3 knocking down inhibition. These findings were confirmed in glioma cells generated patient-derived xenograft models. AMPKα1 protein levels were affected by MG132 treatment in glioma, which suggested EID3 might down regulate AMPKα1 through protein degradation.Conclusion : Collectively, our study demonstrated that EID3 promoted glioma cell proliferation and survival by inhibiting AMPKα1 expression. Targeting EID3 might represent a promising strategy for treating glioma.

EID3 Promotes Glioma Cell Proliferation and Survival by Inactivating AMPKα1

Overexpression of EP300-interacting Inhibitor of Differentiation 3 Predicts Poor Prognosis in Patients with Glioblastoma Multiforme.

EphB3 receptor suppressor invasion, migration and proliferation in glioma by inhibiting EGFR-PI3K/AKT signaling pathway

EEF1E1 Promotes Glioma Proliferation by Regulating Cell Cycle Through PTEN/AKT Signaling Pathway.

KIF3C Promotes Proliferation, Migration, and Invasion of Glioma Cells by Activating the PI3K/AKT Pathway and Inducing EMT

EID3 Promotes Cancer Stem Cell-Like Phenotypes in Osteosarcoma through the Activation of PI3K-AKT Signaling Pathway

Protein Disulfide Isomerase A3 (PDIA3): A Pharmacological Target in Glioblastoma?

E3 ligase MAEA-mediated ubiquitination and degradation of PHD3 promotes glioblastoma progression

MiR‐4524b‐5p‐targeting ALDH1A3 Attenuates the Proliferation and Radioresistance of Glioblastoma Via PI3K/AKT/mTOR Signaling

Glioma Angiogenesis is Boosted by ELK3 Activating the HIF-1 Α /VEGF-A Signaling Axis

KIAA0101 knockdown inhibits glioma progression and glycolysis by inactivating the PI3K/AKT/mTOR pathway

Silencing of TIPE 3 suppresses proliferation of human glioma cells via AKT signaling pathway

UBE2D3 Activates SHP-2 Ubiquitination to Promote Glycolysis and Proliferation of Glioma via Regulating STAT3 Signaling Pathway

GSK-3 beta regulates tumor growth and angiogenesis in human glioma cells

PDIA3 correlates with clinical malignant features and immune signature in human gliomas

CAMK1D Inhibits Glioma Through the PI3K/AKT/mTOR Signaling Pathway

Role of METTL3 in Aerobic Glycolysis of Glioma by Regulating m6A/miR-27b-3p/PDK1

Circadian Period 2 (per2) Downregulate Inhibitor of Differentiation 3 (id3) Expression Via PTEN/AKT/Smad5 Axis to Inhibits Glioma Cell Proliferation

AEG-1 silencing attenuates M2-polarization of glioma-associated microglia/macrophages and sensitizes glioma cells to temozolomide

TMBIM1 Promotes EMT by Stimulating Autophagic Degradation of E-cadherin Via AMPK/mTOR/ULK1 Axis in Human Gliomas

A specific inhibitor of ALDH1A3 regulates retinoic acid biosynthesis in glioma stem cells